Monday, September 11, 2017

All Research Moved To Bio5C

Thanks for visiting BioNap, Inc!

All biopharma equity research has been moved to Bio5C.com. Bio5C is 100% independent biopharma equity research based on my proprietary 5C's of Biotech™ model. The current coverage universe at Bio5C consists of several dozen mid-cap biopharma companies. My criteria include a market capitalization in excess of $100 million and a stock price greater than $5 per share.

At Bio5C, subscribers get the following services for their monthly subscription:

1) 5C Model scores on dozens of biopharma names, including individual component scores: Cash, Catalyst, Charisma, Capital Structure, and Credibility.

2) Daily Notes based on recent news or pending events.

3) Full valuation models on selection Bio5C names in the coverage universe.

4) An Active message board where subscribers can interact with Bio5C and other members.

If you're visiting this website, chances are you've read and appreciated my work in the past. At Bio5C, you get the same quality work from BioNap you've come to expect, with a far more personalized approach and 100% independent thinking. I could use your support, so please visit Bio5C.com and continue reading my work under this new subscription-based model.

Learn more here >> www.bio5c.com/join


If you are an individual or professional investor looking for a custom research report...

or

If you are a biopharma company looking for strategic consulting services, including market research, white papers, or transaction support...

Please email me at jason@bionapinc.com.